TGFBR2 Gene Mutation Analysis
The TGFBR2 gene is located in the short (p) arm of chromosome 3 at position 24.1 and encodes transforming growth factor (TGF), beta-receptor 2. This protein belongs to the Ser/Thr protein kinase family and has a protein kinase domain, forms a heterodimeric complex with another receptor protein, and binds TGF-β. This TGF-β receptor complex phosphorylates proteins and transmits signals which trigger various responses by the cell, including the growth and division (proliferation) of cells, the maturation of cells to carry out specific functions (differentiation), cell movement (motility), and controlled cell death (apoptosis). It can suppress the formation of tumors by preventing uncontrolled growth of cells.
Mutations in this gene are associated with Marfan syndrome, Loeys-Deitz Syndrome, familial thoracic aortic aneurysms and dissections (TAAD) and the development of various types of tumors. Familial thoracic aortic aneurysm and dissection (familial TAAD) involves a permanent, localized dilatation of the thoracic aorta and stretching of the aorta that may lead to a sudden tearing of the layers in the aorta wall (aortic dissection) which can cause life-threatening internal bleeding. The TGFBR2 gene mutations that cause familial TAAD disturb signal transduction, which can impair cell growth and development. Up to 20% of individuals with TAAD who do not have a known syndrome (e.g., Marfan syndrome, vascular Ehlers-Danlos syndrome, or Loeys-Dietz syndrome) have a family history of TAAD. Approximately 30% of families with heritable thoracic aortic disease (HTAD) who do not have a clinical diagnosis of Marfan syndrome or another syndrome have a causative pathogenic variant in one of the known HTAD-related genes.
Loeys-Dietz syndrome (LDS) is an autosomal dominant disorder that can affects connective tissue and blood vessel of the body. TGFBR2 gene mutations that cause Loeys-Dietz syndrome change single amino acid in TGF-β receptor type 2, resulting in a receptor with little or no function. LDS is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. Lastly, there is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease.
Some somatic TGFBR2 gene mutations have an increased risk of developing various cancers. It is estimated that 30 percent of malignant colon tumors harbor TGFBR2 gene mutations.
- Diagnosis of familial thoracic aortic aneurysm and dissection syndrome
- As an aid in diagnosis of TGFBR1-associated Loeys-Dietz and Marfan or Marfan-like syndrome
- To diagnose colon cancers with TGFBR2 gene mutation
- To identify carrier of the familial TGFBR2 mutation by predictive testing in family members
- For the prenatal genetic test in an individual at risk of familial TAAD
- To assist with prognosis, clinical management and surveillance for disease features based on the genetic variant involved
Negative for mutation or pathogenic variant in TGFBR2 gene
Whole blood (EDTA), amniotic fluid (prenatal test).
Stability
- Ambient: 72 hours
- Refrigerated: 1 week
- Frozen: Unacceptable
- Int J Cardiol. 2017 Jan 1;226:21-25. [PMID: 27780078]
- Curr Atheroscler Rep. 2012;14:219-26. [PMID: 22415348]
- Curr Med Chem. 2012;19:454-60. [PMID: 22335518]
- Genes Chromosomes Cancer. 2008;47:95-106. [PMID: 17985359]
- Nat Genet. 2005;37:275-81. [PMID: 15731757]
- Nat Genet 2001 Nov;29(3):351. [PMID: 11586292]
- Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/TGFBR2#